Longitude Capital Partners II LLC 13D/13G Filings for Nabriva Therapeutics plc (NBRVF)

Longitude Capital Partners II LLC 13D and 13G filings for Nabriva Therapeutics plc:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2020-02-12
4:32 pm
Purchase
2019-12-3113GNabriva Therapeutics plc
NBRVF
Longitude Capital Partners II LLC17,026
4.500%
977increase
(+6.08%)
Filing